NCT00210067View on ClinicalTrials.gov

A Study in Subjects With Retinal Detachment

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

June 30, 2002

Study Completion Date

June 30, 2002

Conditions

Retinal Detachment

Interventions

DRUG

denufosol tetrasodium (INS37217) Intravitreal Injection

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00210067 - A Study in Subjects With Retinal Detachment | Biotech Hunter | Biotech Hunter